Literature DB >> 6734693

Reduced peripheral vascular symptoms in elderly patients treated with alpha-methyldopa--a comparison with propranolol.

M J VandenBurg, W D Cooper, M L Woollard, W J Currie, C H Bowker.   

Abstract

A multicentre study of 6-10 weeks duration was performed in 60 ambulant hypertensive patients aged over 60 years to compare the efficacy of methyldopa and propranolol with particular reference to the occurrence of cold extremities and sleep disturbances. Blood pressure was effectively controlled by both drugs being reduced from a mean of 180/108 mmHg to 161/93 with methyldopa and 180/108 to 162/94 with propranolol. More patients treated with methyldopa (74%) achieved the target diastolic blood pressure of 95 mmHg or below compared with those treated with propranolol (58%). Side effects were more frequent in the propranolol group necessitating the withdrawal of four patients from the study. Only one patient on methyldopa was withdrawn. The incidence of cold extremities was significantly greater with propranolol. The occurrence of sleep disturbances was similar in both groups. In this group of elderly patients methyldopa was better tolerated than propranolol.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6734693     DOI: 10.1007/BF00548762

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

1.  Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.

Authors:  F R Bühler; F Burkart; B E Lütold; M Küng; G Marbet; M Pfisterer
Journal:  Am J Cardiol       Date:  1975-10-31       Impact factor: 2.778

2.  Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE).

Authors:  A Amery; P Berthaux; W Birkenhäger; A Boel; P Brixko; C Bulpitt; D Clement; M Deruyttere; A de Schaepdryver; C Dollery; R Fagard; F Forette; J F Henry; J Hellemans; U Laaser; P Lund-Johansen; J MacFarlane; T Maling; A Mutsers; A Nissinen; O H Ohn; J Pelemans; A I Suchettkaye; J Tuomilehto; J Willems
Journal:  Acta Cardiol       Date:  1978       Impact factor: 1.718

3.  Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.

Authors: 
Journal:  JAMA       Date:  1970-08-17       Impact factor: 56.272

Review 4.  Drug therapy: Management of hypertension in the elderly.

Authors:  J Koch-Weser; K O'Malley; E O'Brien
Journal:  N Engl J Med       Date:  1980-06-19       Impact factor: 91.245

5.  Treatment of hypertension in the elderly.

Authors:  G E Bauer
Journal:  Drugs       Date:  1974       Impact factor: 9.546

6.  Future strategies of hypertension control by age.

Authors:  J T Hart
Journal:  J R Coll Gen Pract Occas Pap       Date:  1980-07

7.  Randomised controlled trial of treatment for mild hypertension: design and pilot trial. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

Authors: 
Journal:  Br Med J       Date:  1977-06-04

8.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

9.  The acute and chronic effect of oxprenolol and propranolol on peripheral blood flow in hypertensive patients.

Authors:  M J Vandenburg
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

10.  The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

Authors: 
Journal:  Lancet       Date:  1980-06-14       Impact factor: 202.731

View more
  2 in total

Review 1.  Peripheral vasoconstriction induced by β-adrenoceptor blockers: a systematic review and a network meta-analysis.

Authors:  Charles Khouri; Thomas Jouve; Sophie Blaise; Patrick Carpentier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-05-31       Impact factor: 4.335

2.  The effect of dosing time on the pharmacokinetics and pharmacodynamics of a 'once-a-day' sustained release theophylline preparation.

Authors:  H Lamont; R Pauwels; M Van der Straeten
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.